午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽

5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽

中文名稱5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽
中文同義詞5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽;PPARΓ激動劑(INOLITAZONE DIHYDROCHLORIDE);化合物 T15580;化合物 INOLITAZONE DIHYDROCHLORIDE
英文名稱CS 7017
英文同義詞CS 7017;Inolitazone (dihydrochloride);5-[[4-[[6-(4-Amino-3,5-dimethylphenoxy)-1-methyl-1H-benzimidazol-2-yl]methoxy]phenyl]methyl]-2,4-thiazolidinedione dihydrochloride;Inolitazone (CS-7017) dihydrochloride;RS5444 dihydrochloride;Inolitazone (CS-7017) 2HCl;5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methylbenzimidazol-2-yl]methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;EFATUTAZONE; CS-7017; RS5444; CS 7017; RS 5444
CAS號223132-38-5
分子式C27H28Cl2N4O4S
分子量575.50662
EINECS號
相關類別細胞生物學試劑
Mol文件223132-38-5.mol
結(jié)構式5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽 結(jié)構式

5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽 性質(zhì)

儲存條件Store at -20°C
溶解度DMSO:25 mg/mL(43.44 mM;需要超聲波)H2O:< 0.1 mg/mL(不溶)
形態(tài)粉末
顏色淺紫色至紫色

5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽 用途與合成方法

Inolitazone dihydrochloride (Efatutazone dihydrochloride) 是一種高親和力的 PPARγ 激動劑,活性依賴于 PPARγ,抑制生長,IC50 為 0.8 nM。

PPARγ

Inolitazone dihydrochloride (Efatutazone dihydrochloride) upregulates the cell cycle kinase inhibitor, p21 WAF1/CIP1 . Silencing p21 WAF1/CIP1 rendered cells insensitive to Inolitazone. A 10 nM dose of Inolitazone activates PPARγ:RXRα-dependent transcription as demonstrated in a transient transfection assay utilizing a PPRE response element fused to a luciferase reporter gene (PPRE3-tk-luc). DRO cells are treated in culture with Inolitazone, Rosiglitazone, or Troglitazone at the indicated concentrations. DRO cells are transiently transfected with PPRE3-tk-luc to examine effective concentrations at which EC 50 occurs. The EC 50 s are 1 nM (Inolitazone), 65 nM (Rosiglitazone) and 631 nM (Troglitazone). Similarly, the calculated inhibitory concentration at IC 50 is 0.8 nM for Inolitazone, 75 nM for Rosiglitazone, and 1412 nM for Troglitazone. Inolitazone specifically activates PPARγ, but not PPARα or PPARδ. Exposure of 10 nM Inolitazone following transient transfection with the appropriate PPAR isoform (γ, α, or δ) and PPAR response element linked to a luciferase reporter in RIE rat small intestinal cell line, which does not express PPARs, yields increased luciferase activity only in the presence of PPARγ and PPRE3-tk-luc.
DRO cells are growth inhibited by 10 nM Inolitazone (RS5444) through a PPARγ-dependent mechanism.

Inolitazone dihydrochloride (Efatutazone dihydrochloride) plus Paclitaxel demonstrate additive antiproliferative activity in cell culture and minimal ATC tumor growth. When Inolitazone is administered in the diet to athymic nude mice prior to DRO tumor cell implantation, tumor growth is inhibited in a dose responsive fashion. At the highest dose, 0.025% Inolitazone inhibits growth on day 32 by 94.4% as compared to that of control. In this treatment group, five of 10 animals do not develop demonstrable tumors. In the 0.0025% treatment group, tumor growth is inhibited by 62.3% compared to that of control on day 32 while the 0.00025% dose demonstrated no growth inhibitory activity as compared to control. Tumors is nest allowed to establish in the mouse and began 0.025% Inolitazone treatment of mice 1 week after DRO or ARO tumor cell implantation. Inolitazone treated animals demonstrate tumor growth inhibition of 68.9% in DRO tumors and 48.3% in ARO tumors as compared to that of their respective controls on day 35.

安全信息

MSDS信息

更新日期產(chǎn)品編號產(chǎn)品名稱CAS號包裝價格
2025/05/22HY-14792B5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽
Inolitazone dihydrochloride
223132-38-55mg1600元
2025/05/22HY-14792B5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽
Inolitazone dihydrochloride
223132-38-510 mg2500元

5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽 上下游產(chǎn)品信息

"5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑烷二酮二鹽酸鹽"相關產(chǎn)品信息
丁基氨基甲酸碘代丙炔酯 氯化芐 2,6-二甲基苯胺 N,N-二甲基苯胺 對二甲苯
主頁 | 企業(yè)會員服務 | 廣告業(yè)務 | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 | 評選活動 | HS海關編碼 | MSDS查詢 | 化工站點

Copyright © 2016-2023 ChemicalBook 版權所有  京ICP備07040585號  京公海網(wǎng)安備11010802032676號  

互聯(lián)網(wǎng)增值電信業(yè)務經(jīng)營許可證:京ICP證150597號  互聯(lián)網(wǎng)藥品信息服務資格證編號(京)-非經(jīng)營性-2015-0073  信息系統(tǒng)安全等級保護備案證明(三級)  營業(yè)執(zhí)照公示

本網(wǎng)站展示的所有產(chǎn)品僅用于工業(yè)應用或者科學研究等非醫(yī)療目的,不可用于人類或動物的臨床診斷或者治療,非藥用,非食用。
根據(jù)相關法律法規(guī)和本站規(guī)定,單位或個人購買相關危險物品應取得有效的資質(zhì)、資格條件。

參考《應急管理部等多部門關于加強互聯(lián)網(wǎng)銷售危險化學品安全管理的通知 (應急〔2022〕119號)》《互聯(lián)網(wǎng)危險物品信息發(fā)布管理規(guī)定》